Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
22.50
-0.47 (-2.05%)
Feb 21, 2025, 4:00 PM EST - Market closed
Phibro Animal Health Market Cap
Phibro Animal Health has a market cap or net worth of $911.33 million as of February 21, 2025. Its market cap has increased by 107.97% in one year.
Market Cap
911.33M
Enterprise Value
1.63B
1-Year Change
107.97%
Ranking
Category
Stock Price
$22.50
Market Cap Chart
Since April 11, 2014, Phibro Animal Health's market cap has increased from $642.80M to $911.33M, an increase of 41.78%. That is a compound annual growth rate of 3.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 911.30M | 7.14% |
| Dec 31, 2024 | 850.60M | 81.36% |
| Dec 29, 2023 | 469.00M | -13.66% |
| Dec 30, 2022 | 543.20M | -34.32% |
| Dec 31, 2021 | 827.10M | 5.28% |
| Dec 31, 2020 | 785.60M | -21.79% |
| Dec 31, 2019 | 1.00B | -22.64% |
| Dec 31, 2018 | 1.30B | -3.54% |
| Dec 29, 2017 | 1.35B | 16.59% |
| Dec 30, 2016 | 1.15B | -2.11% |
| Dec 31, 2015 | 1.18B | -4.03% |
| Dec 31, 2014 | 1.23B | 91.19% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |